Evidence map›Paper›PMID 34148359›Full record

ArticleHypertension (Dallas, Tex. : 1979)2021

Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program.

Elvis A Akwo, Cassianne Robinson-Cohen, Cecilia P Chung, Shailja C Shah, Nancy J Brown, T Alp Ikizler, Otis D Wilson, Bryce X Rowan, Megan M Shuey, Edward D Siew and 14 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 9 institutions in 1 country.

Elvis A AkwoDivision of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
Cassianne Robinson-CohenDivision of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
Cecilia P ChungDivision of Rheumatology, Department of Medicine (C.P.C.), Vanderbilt University Medical Center, Nashville, TN.
Shailja C ShahDivision of Gastroenterology, Hepatology and Nutrition (S.C.S.), Vanderbilt University Medical Center, Nashville, TN.
Nancy J BrownDepartment of Medicine (N.J.B., J.M.L.), Vanderbilt University Medical Center, Nashville, TN.
T Alp IkizlerDivision of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
Otis D WilsonDivision of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
Bryce X RowanDepartment of Biostatistics, Vanderbilt School of Medicine (B.X.R, R.T.).
Megan M ShueyDivision of Genetic Medicine, Department of Medicine (M.M.S., J.N.H.), Vanderbilt University Medical Center, Nashville, TN.
Edward D SiewDivision of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
James M LutherDepartment of Medicine (N.J.B., J.M.L.), Vanderbilt University Medical Center, Nashville, TN.
Ayush GiriDivision of Quantitative Sciences, Department of Obstetrics and Gynecology (D.R.V.E., A.G.), Vanderbilt University Medical Center, Nashville, TN.
Jacklyn N HellwegeDivision of Genetic Medicine, Department of Medicine (M.M.S., J.N.H.), Vanderbilt University Medical Center, Nashville, TN.
Digna R Velez EdwardsDivision of Quantitative Sciences, Department of Obstetrics and Gynecology (D.R.V.E., A.G.), Vanderbilt University Medical Center, Nashville, TN.
Christianne L RoumieVeteran Administration Tennessee Valley VA Health Care System Geriatric Research Education Clinical Center (GRECC), Nashville (C.L.R.).
Ran TaoDepartment of Biostatistics, Vanderbilt School of Medicine (B.X.R, R.T.).
Phil S TsaoVA Palo Alto Health Care System (P.S.T.).
J Michael GazianoVA Boston Healthcare System, MA (J.M.G.).
Peter W F WilsonEpidemiology and Genomic Medicine, Atlanta VAMC, Decatur, GA (P.W.F.W.).
Christopher J O'DonnellDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (J.M.G., C.J.O.).
Todd L EdwardsInstitute of Medicine and Public Health (D.R.V.E., T.L.E.), Vanderbilt University Medical Center, Nashville, TN.
Csaba P KovesdyMemphis VA Medical Center, TN (C.P.K.).
Adriana M HungDivision of Nephrology and Hypertension, Department of Medicine (E.A.A., C.R.-C., T.A.I., O.D.W., E.D.S., A.M.H.).
VA Million Veteran Program
VA Tennessee Valley Healthcare System · USVanderbilt University Medical Center · USBrigham and Women's Hospital · USVanderbilt University · USEmory Healthcare · USUniversity of Tennessee Health Science Center · USVanderbilt Health · USVA Palo Alto Health Care System · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Building Interdisciplinary Research Careers in Women's HealthK12HD043483 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTMANN, KATHERINE E, MAJOR, AMY S · 2002 to 2023
$10.3M
Learning Health System Scholar Program at VanderbiltK12HS026395 · AHRQ · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ROTHMAN, RUSSELL L., ROUMIE, CHRISTIANNE L. · 2018 to 2022
$2.7M
Regulatory Role of MicroRNAs in Aging-related Abdominal Aortic Aneurysm DiseaseI01BX002641 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI TSAO, PHILIP S · 2015 to 2019
–
Optimal first line therapies for patients with Cardiovascular-Kidney-Metabolic (CKM) Syndrome.I01CX000570 · VA · VETERANS HEALTH ADMINISTRATION · PI ROUMIE, CHRISTIANNE L. · 2013 to 2025
–
Genetics of CKD and Hypertension-Risk Prediction and Drug Response in the MVPI01CX001897 · VA · VETERANS HEALTH ADMINISTRATION · PI Adriana Hung · 2020 to 2026
–
AHRQ HHS K12 HS026395BLRD VA I01 BX002641BLRD VA I01 BX003360CSRD VA I01 CX000570CSRD VA I01 CX001897CSRD VA IK2 CX002027NCATS NIH HHS UL1 TR001863NICHD NIH HHS K12 HD043483
6 · The paper itself

Abstract

[Figure: see text].

Indexed as

AgedAntihypertensive AgentsApolipoprotein L1Blood PressureComorbidityFemaleGenetic Predisposition to DiseaseGenotypeHumansHypertensionIncidenceKidney Failure, ChronicMaleMiddle AgedMyocardial InfarctionRetrospective StudiesAntihypertensive AgentsApolipoprotein L1apolipoprotein L1 variantsend-stage kidney diseasemyocardial infarctionracestrokeTreatment-resistant hypertension

Identifiers

PMID34148359
PMCPMC8364328
OpenAlexW3176874535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.